Dow Jones futures rose 50 points Thursday ahead of the weekly jobless claims report. Tesla stock declined around 1% in early trade. Read More...
Motley Fool
Why Pfizer Stock Is a Surefire Winner in 2022
Pharmaceutical giant Pfizer (NYSE: PFE) has been at the front of the industry, developing treatments for COVID since the pandemic started. While it’s unfortunate that the world continues to grapple with various strains of the virus, most recently the omicron variant, Pfizer’s products remain in high demand, which will likely boost its 2022 business results. Below we will put some numbers to just how much Pfizer’s treatments boosted its business this year and why 2022 could continue the trend, making it a surefire winning stock this year.
Add Comment